The ` Proteomic prediction and Renin angiotensin aldosterone system Inhibition prevention Of early diabetic nephRopathy In TYpe 2 diabetic patients with normoalbuminuria trial ' ( PRIORITY ) aims to evaluate the early detection of DN in patients with type 2 diabetes ( T2D ) using a urinary proteome-based classifier ( CKD273 ) .